ABACAVIR SULFATE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Abacavir Sulfate, and what generic alternatives are available?
Abacavir Sulfate is a drug marketed by Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Apotex Inc, Cipla, Mylan Pharms Inc, Strides Pharma, Aurobindo Pharma, Laurus, Lupin Ltd, Teva Pharms Usa, and Zydus Pharms. and is included in sixteen NDAs.
The generic ingredient in ABACAVIR SULFATE is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
Summary for ABACAVIR SULFATE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 158 |
Clinical Trials: | 65 |
Patent Applications: | 3,508 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ABACAVIR SULFATE at DailyMed |

Recent Clinical Trials for ABACAVIR SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
ViiV Healthcare | N/A |
University of North Carolina, Chapel Hill | N/A |
National Cancer Institute (NCI) | N/A |
Pharmacology for ABACAVIR SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for ABACAVIR SULFATE
Paragraph IV (Patent) Challenges for ABACAVIR SULFATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ZIAGEN | Oral Solution | abacavir sulfate | 20 mg/mL | 020978 | 1 | 2012-12-27 |
ZIAGEN | Tablets | abacavir sulfate | 300 mg | 020977 | 1 | 2009-01-28 |